668. Presence of the Narrow-Spectrum OXA-1 Beta-Lactamase Enzyme is not Associated with Elevated Ceftolozane-Tazobactam MIC Values among ESBL-Producing Escherichia coli Clinical Isolates (CANWARD, 2011-2018)

BACKGROUND: Beta-lactam-beta-lactamase inhibitor combinations have been proposed as an alternative to carbapenems for the treatment of infections caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli as an antimicrobial stewardship initiative. However, in a recent randomized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Walkty, Andrew, Karlowsky, James, Golden, Alyssa, Lagace-Wiens, Philippe, Baxter, Melanie, Denisuik, Andrew, McCracken, Melissa, Mulvey, Michael, Adam, Heather, Zhanel, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752124/
http://dx.doi.org/10.1093/ofid/ofac492.720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752124/
http://dx.doi.org/10.1093/ofid/ofac492.720

Ejemplares similares